Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Industry sponsorship and research outcome

Lundh, Andreas, Lexchin, Joel, Sismondo, Sergio, Busuioc, Octavian A, Bero, Lisa·2011·Cochrane Database of Systematic Reviews

Abstract

This is a protocol for a Cochrane Review (Methodology). The objectives are as follows: The objectives are to investigate whether: funding of drug studies by the pharmaceutical industry is associated with outcomes that are favorable to the funder; drug studies funded by the pharmaceutical industry differ in their risk of bias compared with studies with other sources of support; funding of device studies by the device industry is associated with outcomes that are favorable to the funder; and device studies funded by the device industry differ in their risk of bias compared with studies with other sources of support.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.mr000033

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 10

  1. Anderson, 1991, Secular changes in published clinical trials of second-line agents in rheumatoid arthritis, Arthritis and Rheumatism, 34, 1304, 10.1002/art.1780341015 · DOI
  2. Anis, 2000, Using economic evaluations to make formulary coverage decisions: so much for guidelines, Pharmacoeconomics, 18, 55, 10.2165/00019053-200018010-00006 · DOI
  3. Bero, 1996, Influences on the quality of published drug studies, International Journal of Technology Assessment in Health Care, 12, 209, 10.1017/S0266462300009582 · DOI · Paper page
  4. Dorman, 1999, Report of randomized trials in acute stroke, 1955 to 1995: what proportions were commercially sponsored?, Stroke, 30, 1995, 10.1161/01.STR.30.10.1995 · DOI
  5. Hill, 2000, Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian pharmaceutical benefits scheme, JAMA, 283, 2116, 10.1001/jama.283.16.2116 · DOI · Paper page
  6. Karlberg, 2008, West to east drift in European sponsored clinical trials, Clinical Trials Magnifier, 1, 101
  7. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011
  8. Sismondo, 2008, How pharmaceutical industry funding affects trial outcomes: casual structures and responses, Social Science and Medicine, 66, 1909, 10.1016/j.socscimed.2008.01.010 · DOI · Paper page
  9. Steinman, 2006, The promotion of gabapentin: an analysis of internal industry documents, Annals of Internal Medicine, 145, 284, 10.7326/0003-4819-145-4-200608150-00008 · DOI · Paper page
  10. Wyatt, 1991, Use and sources of medical knowledge, Lancet, 338, 1368, 10.1016/0140-6736(91)92245-W · DOI · Paper page

Cited by

See all 166

Metadata

Authors
Lundh, A., Lexchin, J., Sismondo, S., Busuioc, O. A., & Bero, L.
Venue
Cochrane Database of Systematic Reviews
Published
2011-09-07
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4243221823
Cited by
166
References
2
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Industry sponsorship and research outcome. https://app.cochat.ai/papers/10.1002/14651858.mr000033
The paper
Lundh, A., Lexchin, J., Sismondo, S., Busuioc, O. A., & Bero, L. (2011). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.mr000033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.